content: <PAGE>
  
                  UNITED STATES SECURITIES AND EXCHANGE COMMISSION
  
                                Washington, DC 20549
  
                                   ______________
  
                                      FORM 8-K
                                   CURRENT REPORT
  
       Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  
          Date of Report (Date of earliest event reported): October 2, 2001
  
                          Commission File Number: 000-28460
  
                          FUSION MEDICAL TECHNOLOGIES, INC.
               (Exact name of registrant as specified in its charter)
  
  
  
                    Delaware                                      94-3177221
                    --------                                      ----------
       (State of incorporation or organization)            (IRS Employer I.D. No.)
  
  
  
                              34715 Ardenwood Boulevard
                              -------------------------
                                  Fremont, CA 94555
                                  -----------------
                      (Address of principal executive offices)
  
                                   (510) 818-4600
                                   --------------
                (Registrant's telephone number, including area code)
  
  <PAGE>
  
           Item 5.  Other Events.
  
           On September 13, 2001, we received notice from Sulzer Spine-Tech Inc.
  that they had filed a Demand for Arbitration with the American Arbitration
  Association for unspecified damages resulting from our alleged breach of
  contract and invalid termination of the International Distributor Agreement
  originally executed between us and Sulzer Spine-Tech on July 1, 1999. Pursuant
  to the International Distributor Agreement, the decision of the arbitrator shall
  be final and non-appealable and shall be delivered within nine (9) months
  following the filing of the initial Demand for Arbitration. We dispute all
  claims made by Sulzer Spine-Tech and intend to vigorously defend ourselves. The
  arbitration and the termination of the International Distributor Agreement may
  result in costly and protracted legal expenses, may divert the efforts of our
  management personnel, may disrupt our revenues as we transition customers to
  order directly from us, may require us to pay monetary damages, may harm our
  reputation and may otherwise materially impact our operations, our business or
  our financial results.
  
  <PAGE>
                                     SIGNATURES
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  registrant has duly caused the report to be signed on its behalf by the
  undersigned thereunto duly authorized.
  
                                                 FUSION MEDICAL TECHNOLOGIES, INC.
  
  
  
                                                 By   /S/ LARRY J. STRAUSS
                                                      ----------------------------
                                                      Larry J. Strauss
  
                                                      Vice President, Finance and
                                                      Chief Financial Officer
                                                      (Chief Accounting Officer
                                                      and Duly Authorized Officer
                                                      of the Registrant)
  
  
  Dated:  October 2, 2001
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "d8k.txt", "description": "CURRENT REPORT", "secsgml_size_bytes": 3386}]
metadata_filer: {"company-data": {"conformed-name": "FUSION MEDICAL TECHNOLOGIES INC", "cik": "0001013466", "assigned-sic": "3841", "irs-number": "943177221", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-28460", "film-number": "1750406"}, "business-address": {"street1": "1615 PLYMOUTH STREET", "city": "MOUNTAIN VIEW", "state": "CA", "zip": "94043", "phone": "4159034000"}, "mail-address": {"street1": "1615 PLYMOUTH STREET", "city": "MOUNTAIN VIEW", "state": "CA", "zip": "94043"}}
text: UNITED STATES SECURITIES AND EXCHANGE COMMISSION
  
                                Washington, DC 20549
  
                                   ______________
  
                                      FORM 8-K
                                   CURRENT REPORT
  
       Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  
          Date of Report (Date of earliest event reported): October 2, 2001
  
                          Commission File Number: 000-28460
  
                          FUSION MEDICAL TECHNOLOGIES, INC.
               (Exact name of registrant as specified in its charter)
  
                    Delaware                                      94-3177221
                    --------                                      ----------
       (State of incorporation or organization)            (IRS Employer I.D. No.)
  
                              34715 Ardenwood Boulevard
                              -------------------------
                                  Fremont, CA 94555
                                  -----------------
                      (Address of principal executive offices)
  
                                   (510) 818-4600
                                   --------------
                (Registrant's telephone number, including area code)
  Item 5.  Other Events.
  
           On September 13, 2001, we received notice from Sulzer Spine-Tech Inc.
  that they had filed a Demand for Arbitration with the American Arbitration
  Association for unspecified damages resulting from our alleged breach of
  contract and invalid termination of the International Distributor Agreement
  originally executed between us and Sulzer Spine-Tech on July 1, 1999. Pursuant
  to the International Distributor Agreement, the decision of the arbitrator shall
  be final and non-appealable and shall be delivered within nine (9) months
  following the filing of the initial Demand for Arbitration. We dispute all
  claims made by Sulzer Spine-Tech and intend to vigorously defend ourselves. The
  arbitration and the termination of the International Distributor Agreement may
  result in costly and protracted legal expenses, may divert the efforts of our
  management personnel, may disrupt our revenues as we transition customers to
  order directly from us, may require us to pay monetary damages, may harm our
  reputation and may otherwise materially impact our operations, our business or
  our financial results.
  SIGNATURES
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  registrant has duly caused the report to be signed on its behalf by the
  undersigned thereunto duly authorized.
  
                                                 FUSION MEDICAL TECHNOLOGIES, INC.
  
                                                 By   /S/ LARRY J. STRAUSS
                                                      ----------------------------
                                                      Larry J. Strauss
  
                                                      Vice President, Finance and
                                                      Chief Financial Officer
                                                      (Chief Accounting Officer
                                                      and Duly Authorized Officer
                                                      of the Registrant)
  
  Dated:  October 2, 2001